Group One Trading, L.P. Evogene Ltd. Transaction History

Group One Trading, L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.7 - $0.98 $700 - $980	-1,001 Reduced 88.82%	126 $0
Q3 2023 Nov 09, 2023	SELL	$0.58 - $1.41 $878 - $2,136	-1,515 Reduced 57.34%	1,127 $0
Q2 2023 Aug 09, 2023	BUY	$0.56 - $1.2 $1,389 - $2,977	2,481 Added 1540.99%	2,642 $2,000
Q1 2023 May 12, 2023	SELL	$0.59 - $0.86 $1,931 - $2,814	-3,273 Reduced 95.31%	161 $0
Q4 2022 Feb 09, 2023	SELL	$0.61 - $8.13 $16,599 - $221,233	-27,212 Reduced 88.79%	3,434 $2,000
Q3 2022 Nov 09, 2022	BUY	$0.73 - $8.65 $6,135 - $72,703	8,405 Added 37.79%	30,646 $25,000
Q2 2022 Aug 11, 2022	SELL	$0.75 - $1.33 $15,716 - $27,870	-20,955 Reduced 48.51%	22,241 $17,000
Q1 2022 May 12, 2022	BUY	$1.09 - $1.83 $21,944 - $36,843	20,133 Added 87.3%	43,196 $56,000
Q4 2021 Feb 11, 2022	BUY	$1.63 - $2.83 $37,592 - $65,268	23,063 New	23,063 $38,000
Q2 2021 Aug 10, 2021	SELL	$3.3 - $5.02 $267 - $406	-81 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$4.29 - $9.94 $347 - $805	81 New	81 $0

117K

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $61.4M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.